What is the most important information I should know about fibrinolysis inhibitor-thrombin topical?

Fibrinolysis inhibitor-thrombin topical is made from human plasma (part of the blood) and may contain infectious agents (e.g., viruses) that can cause disease. Although fibrinolysis inhibitor-thrombin topical is screened, tested, and treated to reduce the possibility that it carries an infectious agent, it can still potentially transmit disease. Discuss with your doctor the risks and benefits of using fibrinolysis inhibitor-thrombin topical.

Contact your doctor if you develop fever, drowsiness, chills, runny nose, rash, joint pain, poor appetite, tiredness, nausea, vomiting, abdominal pain, dark-colored urine, or yellowing of the skin or eyes following treatment with fibrinolysis inhibitor-thrombin topical. These may be symptoms of infections that may occur due to use of this product.

What is fibrinolysis inhibitor-thrombin topical?

Fibrinolysis inhibitor and thrombin are agents that are involved in blood clotting.

Fibrinolysis inhibitor-thrombin topical is used to cause blood clotting during surgery or due to trauma when natural blood clotting processes are deficient.

Fibrinolysis inhibitor-thrombin topical may also be used for purposes other than those listed here.

What should I discuss with my healthcare provider before using fibrinolysis inhibitor-thrombin topical?

Do not use fibrinolysis inhibitor-thrombin topical without first talking to your doctor if you are allergic to cows or products derived from cows.

Fibrinolysis inhibitor-thrombin topical is in the FDA pregnancy category C. This means that it is not known whether it will be harmful to an unborn baby. Do not use fibrinolysis inhibitor-thrombin topical without first talking to your doctor if you are pregnant or could become pregnant during treatment.

It is not known whether fibrinolysis inhibitor-thrombin topical will be harmful to a nursing baby. Do not use fibrinolysis inhibitor-thrombin topical without first talking to your doctor if you are breast-feeding a baby.

How should I use fibrinolysis inhibitor-thrombin topical?

Fibrinolysis inhibitor-thrombin topical will be administered by a healthcare professional as a topical application.

What happens if I miss a dose?

Due to the indications for use and the method of application of fibrinolysis inhibitor-thrombin topical, missing a dose is not likely to occur.

What happens if I overdose?

Due to the indications for use and the method of application of fibrinolysis inhibitor-thrombin topical, an overdose of the medication is unlikely to occur. Contact your doctor or a poison control center for advice if an overdose is suspected.

What should I avoid while taking fibrinolysis inhibitor-thrombin topical?

There are no restrictions on food, beverages, or activity following the use of fibrinolysis inhibitor-thrombin topical, unless otherwise directed by your doctor.

What are the possible side effects of fibrinolysis inhibitor-thrombin topical?

Fibrinolysis inhibitor-thrombin topical is made from human plasma (part of the blood) and may contain infectious agents (e.g., viruses) that can cause disease. Although fibrinolysis inhibitor-thrombin topical is screened, tested, and treated to reduce the possibility that it carries an infectious agent, it can still potentially transmit disease. Discuss with your doctor the risks and benefits of using fibrinolysis inhibitor-thrombin topical.

Contact your doctor if you develop fever, drowsiness, chills, runny nose, rash, joint pain, poor appetite, tiredness, nausea, vomiting, abdominal pain, dark-colored urine, or yellowing of the skin or eyes following treatment with fibrinolysis inhibitor-thrombin topical. These may be symptoms of infections that may occur due to use of this product.

Notify your doctor immediately if you experience a rare but serious allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives) to fibrinolysis inhibitor-thrombin topical.

Other side effects are not expected to occur with the use of fibrinolysis inhibitor-thrombin topical. Talk to your doctor if you experience any side effects from this medication.

What other drugs will affect fibrinolysis inhibitor-thrombin topical

It is not known whether other medications will interact with fibrinolysis inhibitor-thrombin topical. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines, including herbal products during treatment with fibrinolysis inhibitor-thrombin topical.

Where can I get more information?

Your pharmacist has additional information about fibrinolysis inhibitor-thrombin topical written for health professionals that you may read.

What does my medication look like?

Fibrinolysis inhibitor-thrombin topical is available with a prescription under the brand name Tisseel VH Kit. Other brand or generic formulations may also be available. Ask your pharmacist any questions you have about this medication, especially if it is new to you.

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2003 Cerner Multum, Inc. Version: 1.02. Revision date: 2/13/04.